Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.02336960 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.02336960 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.83399847 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.83399847 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 4.70192784 |
6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.41076031 |
7 | coenzyme catabolic process (GO:0009109) | 4.31880197 |
8 | GDP-mannose metabolic process (GO:0019673) | 4.22109905 |
9 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.03090775 |
10 | lysine catabolic process (GO:0006554) | 3.95925573 |
11 | lysine metabolic process (GO:0006553) | 3.95925573 |
12 | cysteine metabolic process (GO:0006534) | 3.93345214 |
13 | response to peptidoglycan (GO:0032494) | 3.87317830 |
14 | glyoxylate metabolic process (GO:0046487) | 3.83628635 |
15 | sulfur amino acid catabolic process (GO:0000098) | 3.74911716 |
16 | ribosomal small subunit biogenesis (GO:0042274) | 3.72948578 |
17 | bile acid biosynthetic process (GO:0006699) | 3.71360457 |
18 | cellular ketone body metabolic process (GO:0046950) | 3.67878009 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.60668818 |
20 | cofactor catabolic process (GO:0051187) | 3.60422084 |
21 | mature B cell differentiation involved in immune response (GO:0002313) | 3.60350419 |
22 | kynurenine metabolic process (GO:0070189) | 3.57799252 |
23 | aspartate family amino acid catabolic process (GO:0009068) | 3.57713757 |
24 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.53057787 |
25 | tryptophan catabolic process (GO:0006569) | 3.51802021 |
26 | indole-containing compound catabolic process (GO:0042436) | 3.51802021 |
27 | indolalkylamine catabolic process (GO:0046218) | 3.51802021 |
28 | alpha-linolenic acid metabolic process (GO:0036109) | 3.50102599 |
29 | valine metabolic process (GO:0006573) | 3.48480358 |
30 | aromatic amino acid family metabolic process (GO:0009072) | 3.44181711 |
31 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40716886 |
32 | tryptophan metabolic process (GO:0006568) | 3.39368237 |
33 | DNA deamination (GO:0045006) | 3.35901685 |
34 | base-excision repair, AP site formation (GO:0006285) | 3.34069390 |
35 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33848231 |
36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33103482 |
37 | mannose metabolic process (GO:0006013) | 3.31969989 |
38 | proline biosynthetic process (GO:0006561) | 3.25772864 |
39 | bile acid metabolic process (GO:0008206) | 3.20282542 |
40 | alpha-amino acid catabolic process (GO:1901606) | 3.18406222 |
41 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.17945904 |
42 | drug transmembrane transport (GO:0006855) | 3.16525317 |
43 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.15247593 |
44 | ketone body metabolic process (GO:1902224) | 3.15033690 |
45 | regulation of cholesterol metabolic process (GO:0090181) | 3.14962801 |
46 | pinocytosis (GO:0006907) | 3.13872619 |
47 | pentose metabolic process (GO:0019321) | 3.13576836 |
48 | 2-oxoglutarate metabolic process (GO:0006103) | 3.13516093 |
49 | response to muramyl dipeptide (GO:0032495) | 3.12700412 |
50 | tyrosine metabolic process (GO:0006570) | 3.11507339 |
51 | regulation of triglyceride catabolic process (GO:0010896) | 3.11456336 |
52 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.10101692 |
53 | cellular amino acid catabolic process (GO:0009063) | 3.09524502 |
54 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.09295332 |
55 | fatty acid catabolic process (GO:0009062) | 3.08714781 |
56 | peroxisome fission (GO:0016559) | 3.07015100 |
57 | deoxyribonucleotide catabolic process (GO:0009264) | 3.02511458 |
58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.02181380 |
59 | negative regulation of phagocytosis (GO:0050765) | 3.01685102 |
60 | UV protection (GO:0009650) | 3.00419938 |
61 | short-chain fatty acid metabolic process (GO:0046459) | 3.00258005 |
62 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.99209715 |
63 | tricarboxylic acid metabolic process (GO:0072350) | 2.99019874 |
64 | fatty acid beta-oxidation (GO:0006635) | 2.97789305 |
65 | fatty acid oxidation (GO:0019395) | 2.96451468 |
66 | high-density lipoprotein particle remodeling (GO:0034375) | 2.96016579 |
67 | aldehyde catabolic process (GO:0046185) | 2.95557164 |
68 | monocarboxylic acid catabolic process (GO:0072329) | 2.95507740 |
69 | cellular modified amino acid catabolic process (GO:0042219) | 2.95469182 |
70 | branched-chain amino acid metabolic process (GO:0009081) | 2.95164882 |
71 | organic acid catabolic process (GO:0016054) | 2.94772923 |
72 | carboxylic acid catabolic process (GO:0046395) | 2.94772923 |
73 | glutamate metabolic process (GO:0006536) | 2.94156092 |
74 | protein maturation by protein folding (GO:0022417) | 2.94058318 |
75 | branched-chain amino acid catabolic process (GO:0009083) | 2.93894688 |
76 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.93098939 |
77 | viral transcription (GO:0019083) | 2.91164447 |
78 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.89542637 |
79 | lipid oxidation (GO:0034440) | 2.88731991 |
80 | deoxyribose phosphate catabolic process (GO:0046386) | 2.88327690 |
81 | regulation of superoxide anion generation (GO:0032928) | 2.87699899 |
82 | intestinal cholesterol absorption (GO:0030299) | 2.87170299 |
83 | creatine metabolic process (GO:0006600) | 2.86988504 |
84 | protein import into peroxisome matrix (GO:0016558) | 2.86253544 |
85 | negative regulation of fibrinolysis (GO:0051918) | 2.85487450 |
86 | dicarboxylic acid catabolic process (GO:0043649) | 2.84250017 |
87 | oxaloacetate metabolic process (GO:0006107) | 2.83971808 |
88 | amino-acid betaine metabolic process (GO:0006577) | 2.81090419 |
89 | signal peptide processing (GO:0006465) | 2.79356339 |
90 | urea metabolic process (GO:0019627) | 2.79304788 |
91 | urea cycle (GO:0000050) | 2.79304788 |
92 | very long-chain fatty acid metabolic process (GO:0000038) | 2.78715753 |
93 | regulation of fibrinolysis (GO:0051917) | 2.78080586 |
94 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75433917 |
95 | protein carboxylation (GO:0018214) | 2.75433917 |
96 | positive regulation of B cell differentiation (GO:0045579) | 2.74621967 |
97 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.73344565 |
98 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.72582334 |
99 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.72482167 |
100 | bile acid and bile salt transport (GO:0015721) | 2.72212066 |
101 | acetyl-CoA metabolic process (GO:0006084) | 2.70301822 |
102 | complement activation, alternative pathway (GO:0006957) | 2.69254355 |
103 | flavonoid metabolic process (GO:0009812) | 2.68979370 |
104 | succinate metabolic process (GO:0006105) | 2.68731693 |
105 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.68043567 |
106 | virion assembly (GO:0019068) | 2.66993986 |
107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66893691 |
108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66893691 |
109 | modulation by symbiont of host immune response (GO:0052553) | 2.66893691 |
110 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66893691 |
111 | modulation by symbiont of host defense response (GO:0052031) | 2.66893691 |
112 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66893691 |
113 | regulation of mast cell degranulation (GO:0043304) | 2.66539755 |
114 | NADH metabolic process (GO:0006734) | 2.66382243 |
115 | drug transport (GO:0015893) | 2.66204668 |
116 | Peyers patch development (GO:0048541) | 2.66117246 |
117 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.66117246 |
118 | negative regulation of cell size (GO:0045792) | 2.66000684 |
119 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.65431599 |
120 | glucose catabolic process (GO:0006007) | 2.65312607 |
121 | response to mercury ion (GO:0046689) | 2.64596785 |
122 | thioester biosynthetic process (GO:0035384) | 2.63626045 |
123 | acyl-CoA biosynthetic process (GO:0071616) | 2.63626045 |
124 | indolalkylamine metabolic process (GO:0006586) | 2.63293207 |
125 | pentose-phosphate shunt (GO:0006098) | 2.62706150 |
126 | serine family amino acid biosynthetic process (GO:0009070) | 2.62559153 |
127 | serine family amino acid metabolic process (GO:0009069) | 2.62330617 |
128 | acyl-CoA metabolic process (GO:0006637) | 2.61720024 |
129 | thioester metabolic process (GO:0035383) | 2.61720024 |
130 | small molecule catabolic process (GO:0044282) | 2.61646612 |
131 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.61221976 |
132 | peroxisome organization (GO:0007031) | 2.61014252 |
133 | detection of bacterium (GO:0016045) | 2.60306264 |
134 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.60295925 |
135 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60253318 |
136 | neutrophil activation involved in immune response (GO:0002283) | 2.59936808 |
137 | fatty acid elongation (GO:0030497) | 2.59734251 |
138 | NADPH regeneration (GO:0006740) | 2.59177001 |
139 | coenzyme A metabolic process (GO:0015936) | 2.58857802 |
140 | response to methylmercury (GO:0051597) | 2.58847558 |
141 | nitrogen cycle metabolic process (GO:0071941) | 2.58349746 |
142 | snRNA metabolic process (GO:0016073) | 2.58122904 |
143 | heme transport (GO:0015886) | 2.57292038 |
144 | COPI coating of Golgi vesicle (GO:0048205) | 2.57283123 |
145 | Golgi transport vesicle coating (GO:0048200) | 2.57283123 |
146 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.57212479 |
147 | immunoglobulin mediated immune response (GO:0016064) | 2.57137339 |
148 | regulation of plasminogen activation (GO:0010755) | 2.56264303 |
149 | regulation of protein activation cascade (GO:2000257) | 2.55899202 |
150 | nucleotide salvage (GO:0043173) | 2.53357761 |
151 | translational termination (GO:0006415) | 2.52367387 |
152 | mature B cell differentiation (GO:0002335) | 2.51458645 |
153 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.50575384 |
154 | regulation of leukocyte degranulation (GO:0043300) | 2.50456941 |
155 | translational elongation (GO:0006414) | 2.49087828 |
156 | dosage compensation (GO:0007549) | 2.48806435 |
157 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.48008770 |
158 | negative regulation of necroptotic process (GO:0060546) | 2.47219445 |
159 | positive thymic T cell selection (GO:0045059) | 2.46380482 |
160 | thymic T cell selection (GO:0045061) | 2.46124039 |
161 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.45210657 |
162 | protein-DNA complex disassembly (GO:0032986) | 2.45090099 |
163 | nucleosome disassembly (GO:0006337) | 2.45090099 |
164 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.43842156 |
165 | detection of other organism (GO:0098543) | 2.42170524 |
166 | negative regulation of B cell apoptotic process (GO:0002903) | 2.41956219 |
167 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.41932116 |
168 | negative regulation of cell killing (GO:0031342) | 2.41932116 |
169 | positive regulation of granulocyte differentiation (GO:0030854) | 2.41792226 |
170 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.40395299 |
171 | regulation of translational fidelity (GO:0006450) | 2.39634596 |
172 | cellular response to interleukin-4 (GO:0071353) | 2.38891167 |
173 | histone H3-K36 demethylation (GO:0070544) | 2.38471737 |
174 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.38110044 |
175 | ribosomal small subunit assembly (GO:0000028) | 2.37233263 |
176 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.36976488 |
177 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.36385498 |
178 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.35302433 |
179 | pyrimidine nucleoside salvage (GO:0043097) | 2.34974272 |
180 | pyrimidine-containing compound salvage (GO:0008655) | 2.34974272 |
181 | purine nucleotide salvage (GO:0032261) | 2.33996062 |
182 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.32387336 |
183 | maturation of SSU-rRNA (GO:0030490) | 2.32230127 |
184 | definitive hemopoiesis (GO:0060216) | 2.31837256 |
185 | snRNA processing (GO:0016180) | 2.30512790 |
186 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.30447513 |
187 | modulation by virus of host process (GO:0019054) | 2.30323623 |
188 | DNA strand elongation (GO:0022616) | 2.30309994 |
189 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.30079335 |
190 | viral life cycle (GO:0019058) | 2.29755757 |
191 | apoptotic process involved in morphogenesis (GO:0060561) | 2.28640283 |
192 | regulation of necrotic cell death (GO:0010939) | 2.28417598 |
193 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.28074550 |
194 | granulocyte differentiation (GO:0030851) | 2.26514033 |
195 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.26210952 |
196 | protein retention in ER lumen (GO:0006621) | 2.25415460 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.89726058 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.94536205 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.14756072 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.87259117 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.43433382 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.30855519 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.21635033 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.12946261 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.90085662 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.73251381 |
11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47617497 |
12 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.37308661 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.35845185 |
14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.17835054 |
15 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.16835285 |
16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.13432066 |
17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.00111224 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97029632 |
19 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95107835 |
20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.93702948 |
21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93585038 |
22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.84143191 |
23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.84064034 |
24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81187901 |
25 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.80716325 |
26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.78922706 |
27 | MAF_26560356_Chip-Seq_TH1_Human | 1.76419044 |
28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75964009 |
29 | MAF_26560356_Chip-Seq_TH2_Human | 1.74264460 |
30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.74120089 |
31 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.72957282 |
32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.72265633 |
33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72051000 |
34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71443007 |
35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67128028 |
36 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65469369 |
37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63344732 |
38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62390468 |
39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.60371001 |
40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.58294589 |
41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57939096 |
42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.56853033 |
43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55025180 |
44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49685496 |
45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.48445700 |
46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47017939 |
47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45251472 |
48 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.42146891 |
49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40304031 |
50 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.39092996 |
51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38728334 |
52 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.38651566 |
53 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.38216954 |
54 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37059041 |
55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36912990 |
56 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.36909083 |
57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36233687 |
58 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.32108689 |
59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31724927 |
60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31495774 |
61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31195973 |
62 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.31157048 |
63 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29634385 |
64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29092362 |
65 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28125379 |
66 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27534133 |
67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26323967 |
68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24971438 |
69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24751960 |
70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23996536 |
71 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.23631067 |
72 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.22443038 |
73 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22177973 |
74 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21979050 |
75 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.21513945 |
76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21326262 |
77 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20330614 |
78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.20042912 |
79 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.19886581 |
80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.19483789 |
81 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17812590 |
82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17441529 |
83 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14469399 |
84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14190883 |
85 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14033953 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13800862 |
87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13319282 |
88 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11780086 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11583612 |
90 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.11181961 |
91 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10743174 |
92 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10725506 |
93 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.10332094 |
94 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09819213 |
95 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.09638386 |
96 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08925589 |
97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07566243 |
98 | MYB_26560356_Chip-Seq_TH1_Human | 1.07265399 |
99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06950858 |
100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06866830 |
101 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06272690 |
102 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06186084 |
103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.05343286 |
104 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05071994 |
105 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04117826 |
106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.03043917 |
107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01996069 |
108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01488206 |
109 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00147657 |
110 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99998184 |
111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99720886 |
112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99061560 |
113 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98304197 |
114 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98000915 |
115 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97296958 |
116 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97075416 |
117 | P68_20966046_ChIP-Seq_HELA_Human | 0.96273497 |
118 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.95111079 |
119 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94321596 |
120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.93995544 |
121 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93022072 |
122 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.92592082 |
123 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91545122 |
124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90464014 |
125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89942475 |
126 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89450325 |
127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89317589 |
128 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89311852 |
129 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89262070 |
130 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87009036 |
131 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86536612 |
132 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.85853846 |
133 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83489745 |
134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.82792246 |
135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.82674416 |
136 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.82525331 |
137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82446205 |
138 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81898331 |
139 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.81843062 |
140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81642054 |
141 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.80264768 |
142 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.80256253 |
143 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79734426 |
144 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.79506860 |
145 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.79431812 |
146 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77901264 |
147 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77390287 |
148 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.77139995 |
149 | MYC_22102868_ChIP-Seq_BL_Human | 0.76896580 |
150 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.76489257 |
151 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.76020858 |
152 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75464042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.76761338 |
2 | MP0005360_urolithiasis | 4.58004652 |
3 | MP0005365_abnormal_bile_salt | 4.41977638 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.86556290 |
5 | MP0005085_abnormal_gallbladder_physiolo | 3.81599703 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.37117940 |
7 | MP0009278_abnormal_bone_marrow | 3.03742463 |
8 | MP0003436_decreased_susceptibility_to | 2.76866431 |
9 | MP0002132_abnormal_respiratory_system | 2.72106522 |
10 | MP0005083_abnormal_biliary_tract | 2.70541319 |
11 | MP0010329_abnormal_lipoprotein_level | 2.69341874 |
12 | MP0001666_abnormal_nutrient_absorption | 2.49202723 |
13 | MP0003195_calcinosis | 2.46855612 |
14 | MP0008260_abnormal_autophagy | 2.43098492 |
15 | MP0005464_abnormal_platelet_physiology | 2.41602073 |
16 | MP0003763_abnormal_thymus_physiology | 2.39476461 |
17 | MP0002396_abnormal_hematopoietic_system | 2.36649431 |
18 | MP0004043_abnormal_pH_regulation | 2.35717745 |
19 | MP0005332_abnormal_amino_acid | 2.33229543 |
20 | MP0005397_hematopoietic_system_phenotyp | 2.24105988 |
21 | MP0001545_abnormal_hematopoietic_system | 2.24105988 |
22 | MP0009840_abnormal_foam_cell | 2.19415750 |
23 | MP0003868_abnormal_feces_composition | 2.19201517 |
24 | MP0005058_abnormal_lysosome_morphology | 2.16707268 |
25 | MP0003252_abnormal_bile_duct | 2.08460325 |
26 | MP0006036_abnormal_mitochondrial_physio | 2.08151487 |
27 | MP0001835_abnormal_antigen_presentation | 2.06384565 |
28 | MP0003656_abnormal_erythrocyte_physiolo | 2.01691821 |
29 | MP0005636_abnormal_mineral_homeostasis | 1.97250767 |
30 | MP0005025_abnormal_response_to | 1.96935353 |
31 | MP0004185_abnormal_adipocyte_glucose | 1.94930116 |
32 | MP0002118_abnormal_lipid_homeostasis | 1.94767705 |
33 | MP0009333_abnormal_splenocyte_physiolog | 1.93003424 |
34 | MP0003303_peritoneal_inflammation | 1.91761789 |
35 | MP0002837_dystrophic_cardiac_calcinosis | 1.88185099 |
36 | MP0002419_abnormal_innate_immunity | 1.86580874 |
37 | MP0003329_amyloid_beta_deposits | 1.79092560 |
38 | MP0004147_increased_porphyrin_level | 1.74934392 |
39 | MP0002876_abnormal_thyroid_physiology | 1.70977985 |
40 | MP0002420_abnormal_adaptive_immunity | 1.69645005 |
41 | MP0009643_abnormal_urine_homeostasis | 1.67801862 |
42 | MP0001819_abnormal_immune_cell | 1.67577895 |
43 | MP0002398_abnormal_bone_marrow | 1.66523785 |
44 | MP0000013_abnormal_adipose_tissue | 1.64622549 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.63810469 |
46 | MP0000609_abnormal_liver_physiology | 1.63417783 |
47 | MP0005000_abnormal_immune_tolerance | 1.62669952 |
48 | MP0002909_abnormal_adrenal_gland | 1.58639376 |
49 | MP0001765_abnormal_ion_homeostasis | 1.58410302 |
50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57329316 |
51 | MP0002723_abnormal_immune_serum | 1.56321634 |
52 | MP0000858_altered_metastatic_potential | 1.55951671 |
53 | MP0001800_abnormal_humoral_immune | 1.53872589 |
54 | MP0002722_abnormal_immune_system | 1.53610138 |
55 | MP0001849_ear_inflammation | 1.52129350 |
56 | MP0002452_abnormal_antigen_presenting | 1.50809650 |
57 | MP0005220_abnormal_exocrine_pancreas | 1.49841912 |
58 | MP0003191_abnormal_cellular_cholesterol | 1.48196250 |
59 | MP0005319_abnormal_enzyme/_coenzyme | 1.47790210 |
60 | MP0000716_abnormal_immune_system | 1.44631482 |
61 | MP0001986_abnormal_taste_sensitivity | 1.44511104 |
62 | MP0000685_abnormal_immune_system | 1.44130749 |
63 | MP0003111_abnormal_nucleus_morphology | 1.42615858 |
64 | MP0002429_abnormal_blood_cell | 1.42262673 |
65 | MP0000490_abnormal_crypts_of | 1.41792706 |
66 | MP0000703_abnormal_thymus_morphology | 1.41740602 |
67 | MP0003693_abnormal_embryo_hatching | 1.39596604 |
68 | MP0000747_muscle_weakness | 1.38159040 |
69 | MP0001764_abnormal_homeostasis | 1.36961900 |
70 | MP0002078_abnormal_glucose_homeostasis | 1.34643314 |
71 | MP0005451_abnormal_body_composition | 1.34409369 |
72 | MP0000689_abnormal_spleen_morphology | 1.34376789 |
73 | MP0004947_skin_inflammation | 1.31825563 |
74 | MP0000681_abnormal_thyroid_gland | 1.31741632 |
75 | MP0004859_abnormal_synaptic_plasticity | 1.29536150 |
76 | MP0000604_amyloidosis | 1.28312878 |
77 | MP0003724_increased_susceptibility_to | 1.27949543 |
78 | MP0001944_abnormal_pancreas_morphology | 1.27909228 |
79 | MP0002019_abnormal_tumor_incidence | 1.25134035 |
80 | MP0005387_immune_system_phenotype | 1.25126388 |
81 | MP0001790_abnormal_immune_system | 1.25126388 |
82 | MP0002693_abnormal_pancreas_physiology | 1.23937660 |
83 | MP0010155_abnormal_intestine_physiology | 1.23470029 |
84 | MP0004381_abnormal_hair_follicle | 1.22302661 |
85 | MP0004019_abnormal_vitamin_homeostasis | 1.21213123 |
86 | MP0002148_abnormal_hypersensitivity_rea | 1.20072606 |
87 | MP0002405_respiratory_system_inflammati | 1.19730462 |
88 | MP0004808_abnormal_hematopoietic_stem | 1.18632628 |
89 | MP0005535_abnormal_body_temperature | 1.17963552 |
90 | MP0005666_abnormal_adipose_tissue | 1.17935599 |
91 | MP0001756_abnormal_urination | 1.17597058 |
92 | MP0010094_abnormal_chromosome_stability | 1.16767448 |
93 | MP0002822_catalepsy | 1.14347977 |
94 | MP0009785_altered_susceptibility_to | 1.13000219 |
95 | MP0004270_analgesia | 1.12136340 |
96 | MP0003866_abnormal_defecation | 1.11252408 |
97 | MP0001853_heart_inflammation | 1.10640789 |
98 | MP0001873_stomach_inflammation | 1.09954844 |
99 | MP0004264_abnormal_extraembryonic_tissu | 1.09555421 |
100 | MP0002877_abnormal_melanocyte_morpholog | 1.08176608 |
101 | MP0001845_abnormal_inflammatory_respons | 1.07802135 |
102 | MP0005075_abnormal_melanosome_morpholog | 1.06299915 |
103 | MP0001533_abnormal_skeleton_physiology | 1.05666321 |
104 | MP0005501_abnormal_skin_physiology | 1.04773882 |
105 | MP0006035_abnormal_mitochondrial_morpho | 1.04597229 |
106 | MP0002138_abnormal_hepatobiliary_system | 1.03804612 |
107 | MP0000920_abnormal_myelination | 1.03315509 |
108 | MP0003183_abnormal_peptide_metabolism | 1.03117173 |
109 | MP0000313_abnormal_cell_death | 1.02164895 |
110 | MP0002064_seizures | 1.01416047 |
111 | MP0003880_abnormal_central_pattern | 0.99615383 |
112 | MP0004233_abnormal_muscle_weight | 0.97970273 |
113 | MP0009642_abnormal_blood_homeostasis | 0.96277555 |
114 | MP0001348_abnormal_lacrimal_gland | 0.95003508 |
115 | MP0005671_abnormal_response_to | 0.94670894 |
116 | MP0002272_abnormal_nervous_system | 0.94457378 |
117 | MP0006276_abnormal_autonomic_nervous | 0.93081334 |
118 | MP0008469_abnormal_protein_level | 0.92278691 |
119 | MP0003172_abnormal_lysosome_physiology | 0.91388432 |
120 | MP0004145_abnormal_muscle_electrophysio | 0.90243468 |
121 | MP0004130_abnormal_muscle_cell | 0.90233313 |
122 | MP0009697_abnormal_copulation | 0.89388425 |
123 | MP0003077_abnormal_cell_cycle | 0.89354130 |
124 | MP0003186_abnormal_redox_activity | 0.88531258 |
125 | MP0000598_abnormal_liver_morphology | 0.88023344 |
126 | MP0003635_abnormal_synaptic_transmissio | 0.88011290 |
127 | MP0000230_abnormal_systemic_arterial | 0.87831542 |
128 | MP0003705_abnormal_hypodermis_morpholog | 0.87605789 |
129 | MP0000015_abnormal_ear_pigmentation | 0.86711295 |
130 | MP0003953_abnormal_hormone_level | 0.85748586 |
131 | MP0003959_abnormal_lean_body | 0.85688644 |
132 | MP0005076_abnormal_cell_differentiation | 0.85503745 |
133 | MP0002249_abnormal_larynx_morphology | 0.85133171 |
134 | MP0005084_abnormal_gallbladder_morpholo | 0.84379847 |
135 | MP0002736_abnormal_nociception_after | 0.83445091 |
136 | MP0002735_abnormal_chemical_nociception | 0.83409646 |
137 | MP0005409_darkened_coat_color | 0.81651520 |
138 | MP0001529_abnormal_vocalization | 0.81613471 |
139 | MP0009745_abnormal_behavioral_response | 0.81092076 |
140 | MP0005448_abnormal_energy_balance | 0.80771887 |
141 | MP0009379_abnormal_foot_pigmentation | 0.80487723 |
142 | MP0009931_abnormal_skin_appearance | 0.79905381 |
143 | MP0010386_abnormal_urinary_bladder | 0.79397816 |
144 | MP0002229_neurodegeneration | 0.78690449 |
145 | MP0002733_abnormal_thermal_nociception | 0.78328281 |
146 | MP0000343_altered_response_to | 0.76791541 |
147 | MP0001970_abnormal_pain_threshold | 0.76330787 |
148 | MP0003315_abnormal_perineum_morphology | 0.76247931 |
149 | MP0005410_abnormal_fertilization | 0.76004300 |
150 | MP0001664_abnormal_digestion | 0.75039246 |
151 | MP0005379_endocrine/exocrine_gland_phen | 0.74939481 |
152 | MP0008961_abnormal_basal_metabolism | 0.73950043 |
153 | MP0004858_abnormal_nervous_system | 0.73927084 |
154 | MP0003633_abnormal_nervous_system | 0.72322151 |
155 | MP0000350_abnormal_cell_proliferation | 0.72235707 |
156 | MP0003786_premature_aging | 0.71978921 |
157 | MP0003300_gastrointestinal_ulcer | 0.71104612 |
158 | MP0000678_abnormal_parathyroid_gland | 0.70919283 |
159 | MP0001968_abnormal_touch/_nociception | 0.70612715 |
160 | MP0003879_abnormal_hair_cell | 0.70066235 |
161 | MP0000358_abnormal_cell_content/ | 0.69239992 |
162 | MP0005621_abnormal_cell_physiology | 0.69105139 |
163 | MP0005375_adipose_tissue_phenotype | 0.67902467 |
164 | MP0005330_cardiomyopathy | 0.67332323 |
165 | MP0002970_abnormal_white_adipose | 0.67155387 |
166 | MP0002796_impaired_skin_barrier | 0.66867141 |
167 | MP0003453_abnormal_keratinocyte_physiol | 0.65935444 |
168 | MP0004142_abnormal_muscle_tone | 0.64607987 |
169 | MP0001661_extended_life_span | 0.64429876 |
170 | MP0001730_embryonic_growth_arrest | 0.64345366 |
171 | MP0008007_abnormal_cellular_replicative | 0.64223644 |
172 | MP0001905_abnormal_dopamine_level | 0.64105251 |
173 | MP0000003_abnormal_adipose_tissue | 0.63958270 |
174 | MP0005334_abnormal_fat_pad | 0.63920721 |
175 | MP0008569_lethality_at_weaning | 0.63094118 |
176 | MP0003638_abnormal_response/metabolism_ | 0.62988343 |
177 | MP0002572_abnormal_emotion/affect_behav | 0.62599390 |
178 | MP0008873_increased_physiological_sensi | 0.62169443 |
179 | MP0002971_abnormal_brown_adipose | 0.62018882 |
180 | MP0002069_abnormal_eating/drinking_beha | 0.60209945 |
181 | MP0002136_abnormal_kidney_physiology | 0.60147084 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.69737354 |
2 | Ketosis (HP:0001946) | 4.03185613 |
3 | Intrahepatic cholestasis (HP:0001406) | 3.84465295 |
4 | Ketoacidosis (HP:0001993) | 3.75320341 |
5 | Hyperlipoproteinemia (HP:0010980) | 3.63454530 |
6 | Xanthomatosis (HP:0000991) | 3.63259975 |
7 | Chronic obstructive pulmonary disease (HP:0006510) | 3.63257922 |
8 | Obstructive lung disease (HP:0006536) | 3.63257922 |
9 | Hypertensive crisis (HP:0100735) | 3.56660110 |
10 | Petechiae (HP:0000967) | 3.53699829 |
11 | Hypoglycemic coma (HP:0001325) | 3.44942121 |
12 | Vacuolated lymphocytes (HP:0001922) | 3.42055261 |
13 | Prolonged partial thromboplastin time (HP:0003645) | 3.39273009 |
14 | Pheochromocytoma (HP:0002666) | 3.37050002 |
15 | Progressive muscle weakness (HP:0003323) | 3.35004487 |
16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.30765138 |
17 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.29571087 |
18 | Deep venous thrombosis (HP:0002625) | 3.29471807 |
19 | Seborrheic dermatitis (HP:0001051) | 3.29110021 |
20 | Ragged-red muscle fibers (HP:0003200) | 3.23675218 |
21 | Gout (HP:0001997) | 3.11151132 |
22 | Colitis (HP:0002583) | 3.11099168 |
23 | Late onset (HP:0003584) | 3.08228986 |
24 | Neuroendocrine neoplasm (HP:0100634) | 3.07497690 |
25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00382870 |
26 | Eczematoid dermatitis (HP:0000976) | 2.94072387 |
27 | Gastrointestinal inflammation (HP:0004386) | 2.92795491 |
28 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.92038416 |
29 | Hypobetalipoproteinemia (HP:0003563) | 2.82368542 |
30 | Prolonged bleeding time (HP:0003010) | 2.81007282 |
31 | Cellulitis (HP:0100658) | 2.80053718 |
32 | Generalized aminoaciduria (HP:0002909) | 2.79367940 |
33 | Hepatosplenomegaly (HP:0001433) | 2.78579754 |
34 | Spontaneous abortion (HP:0005268) | 2.78028520 |
35 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.77832177 |
36 | Dicarboxylic aciduria (HP:0003215) | 2.77832177 |
37 | Hepatic necrosis (HP:0002605) | 2.77525640 |
38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.73898359 |
39 | Abnormality of macrophages (HP:0004311) | 2.69510844 |
40 | Hyperammonemia (HP:0001987) | 2.69056437 |
41 | Recurrent abscess formation (HP:0002722) | 2.64854899 |
42 | Panhypogammaglobulinemia (HP:0003139) | 2.64629458 |
43 | Brushfield spots (HP:0001088) | 2.63406098 |
44 | Recurrent fungal infections (HP:0002841) | 2.63158316 |
45 | Reticulocytosis (HP:0001923) | 2.62531887 |
46 | Inflammation of the large intestine (HP:0002037) | 2.59300952 |
47 | Fat malabsorption (HP:0002630) | 2.58146860 |
48 | Reduced antithrombin III activity (HP:0001976) | 2.57314529 |
49 | Abnormality of glycine metabolism (HP:0010895) | 2.55196065 |
50 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55196065 |
51 | Epistaxis (HP:0000421) | 2.54971455 |
52 | Recurrent viral infections (HP:0004429) | 2.52323844 |
53 | Abnormal gallbladder physiology (HP:0012438) | 2.50921591 |
54 | Cholecystitis (HP:0001082) | 2.50921591 |
55 | Cerebral hemorrhage (HP:0001342) | 2.49131803 |
56 | Hyperglycinuria (HP:0003108) | 2.47885963 |
57 | Cerebral edema (HP:0002181) | 2.46718379 |
58 | Hyperthyroidism (HP:0000836) | 2.46631730 |
59 | Hyperbilirubinemia (HP:0002904) | 2.46559558 |
60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.45752475 |
61 | Myopathic facies (HP:0002058) | 2.43926449 |
62 | Hyperglycinemia (HP:0002154) | 2.43847436 |
63 | Hepatocellular necrosis (HP:0001404) | 2.43593112 |
64 | Recurrent bacterial skin infections (HP:0005406) | 2.42222981 |
65 | Abnormality of reticulocytes (HP:0004312) | 2.40158103 |
66 | Microvesicular hepatic steatosis (HP:0001414) | 2.39462321 |
67 | Broad distal phalanx of finger (HP:0009836) | 2.38223586 |
68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38222536 |
69 | Type I transferrin isoform profile (HP:0003642) | 2.37765058 |
70 | Hypoglycemic seizures (HP:0002173) | 2.36816310 |
71 | Thoracic kyphosis (HP:0002942) | 2.35802935 |
72 | Posterior subcapsular cataract (HP:0007787) | 2.35133372 |
73 | Abnormality of the common coagulation pathway (HP:0010990) | 2.35084428 |
74 | Nasal polyposis (HP:0100582) | 2.35041943 |
75 | Meningitis (HP:0001287) | 2.34543092 |
76 | Metabolic acidosis (HP:0001942) | 2.33725277 |
77 | Purpura (HP:0000979) | 2.32805174 |
78 | Abnormality of purine metabolism (HP:0004352) | 2.31547489 |
79 | Granulocytopenia (HP:0001913) | 2.30800710 |
80 | Truncus arteriosus (HP:0001660) | 2.30463336 |
81 | Abnormality of the intrinsic pathway (HP:0010989) | 2.30139290 |
82 | Acute encephalopathy (HP:0006846) | 2.28764839 |
83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27010365 |
84 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27010365 |
85 | Atelectasis (HP:0100750) | 2.26248884 |
86 | Symptomatic seizures (HP:0011145) | 2.26027799 |
87 | Oligomenorrhea (HP:0000876) | 2.25139757 |
88 | Agammaglobulinemia (HP:0004432) | 2.23908265 |
89 | Tinnitus (HP:0000360) | 2.23629658 |
90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23343780 |
91 | Exercise-induced myalgia (HP:0003738) | 2.23212016 |
92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23054315 |
93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23054315 |
94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23054315 |
95 | Lethargy (HP:0001254) | 2.22771545 |
96 | J-shaped sella turcica (HP:0002680) | 2.22583707 |
97 | Abnormal protein glycosylation (HP:0012346) | 2.21325266 |
98 | Abnormal glycosylation (HP:0012345) | 2.21325266 |
99 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21325266 |
100 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21325266 |
101 | Rhabdomyolysis (HP:0003201) | 2.19989293 |
102 | Myositis (HP:0100614) | 2.17370778 |
103 | Vertebral compression fractures (HP:0002953) | 2.15504796 |
104 | Complement deficiency (HP:0004431) | 2.14021223 |
105 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12141158 |
106 | Abnormality of the nasal mucosa (HP:0000433) | 2.11827646 |
107 | Hypolipoproteinemia (HP:0010981) | 2.11162246 |
108 | Mediastinal lymphadenopathy (HP:0100721) | 2.10990206 |
109 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10856093 |
110 | Steatorrhea (HP:0002570) | 2.10649839 |
111 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.10185768 |
112 | Abnormality of the columella (HP:0009929) | 2.09674782 |
113 | Polycythemia (HP:0001901) | 2.07811791 |
114 | Pustule (HP:0200039) | 2.07448901 |
115 | Alkalosis (HP:0001948) | 2.07300024 |
116 | Impaired platelet aggregation (HP:0003540) | 2.07224692 |
117 | Abnormal platelet function (HP:0011869) | 2.07224692 |
118 | Increased IgE level (HP:0003212) | 2.07161865 |
119 | Dysostosis multiplex (HP:0000943) | 2.06910293 |
120 | Easy fatigability (HP:0003388) | 2.06042510 |
121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.05977679 |
122 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.05977679 |
123 | Recurrent skin infections (HP:0001581) | 2.04452082 |
124 | Lactic acidosis (HP:0003128) | 2.04415073 |
125 | Abnormal gallbladder morphology (HP:0012437) | 2.03969934 |
126 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.02839856 |
127 | Epiphyseal stippling (HP:0010655) | 2.02618846 |
128 | Spastic paraparesis (HP:0002313) | 2.02505720 |
129 | Microretrognathia (HP:0000308) | 2.01766379 |
130 | Abnormality of the thoracic spine (HP:0100711) | 2.00908430 |
131 | Mitochondrial inheritance (HP:0001427) | 2.00701351 |
132 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.99806013 |
133 | Muscle stiffness (HP:0003552) | 1.99616434 |
134 | Joint hemorrhage (HP:0005261) | 1.99519174 |
135 | Increased muscle lipid content (HP:0009058) | 1.99388931 |
136 | Irritability (HP:0000737) | 1.98777463 |
137 | Hemorrhage of the eye (HP:0011885) | 1.97515052 |
138 | Vomiting (HP:0002013) | 1.97384380 |
139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.96006932 |
140 | Pallor (HP:0000980) | 1.95452418 |
141 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93279736 |
142 | Reticulocytopenia (HP:0001896) | 1.92924559 |
143 | Abnormality of methionine metabolism (HP:0010901) | 1.92339232 |
144 | Retinal dysplasia (HP:0007973) | 1.92168305 |
145 | Hypertriglyceridemia (HP:0002155) | 1.90958625 |
146 | Gastrointestinal dysmotility (HP:0002579) | 1.90536714 |
147 | Acute necrotizing encephalopathy (HP:0006965) | 1.89612107 |
148 | Hypoalphalipoproteinemia (HP:0003233) | 1.89598826 |
149 | Increased purine levels (HP:0004368) | 1.89357617 |
150 | Hyperuricemia (HP:0002149) | 1.89357617 |
151 | Methylmalonic aciduria (HP:0012120) | 1.89279244 |
152 | Bowel incontinence (HP:0002607) | 1.88716413 |
153 | Delayed CNS myelination (HP:0002188) | 1.88484287 |
154 | Abnormal large intestine physiology (HP:0012700) | 1.87759806 |
155 | Abnormality of serum amino acid levels (HP:0003112) | 1.87299190 |
156 | Cholelithiasis (HP:0001081) | 1.86333012 |
157 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.85390662 |
158 | Increased serum ferritin (HP:0003281) | 1.85020138 |
159 | Pancreatitis (HP:0001733) | 1.84030448 |
160 | Abnormal number of erythroid precursors (HP:0012131) | 1.83291628 |
161 | Increased cerebral lipofuscin (HP:0011813) | 1.83245798 |
162 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83076451 |
163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82480054 |
164 | Opisthotonus (HP:0002179) | 1.81154444 |
165 | Abnormality of nucleobase metabolism (HP:0010932) | 1.81080731 |
166 | Flattened epiphyses (HP:0003071) | 1.80818732 |
167 | Increased intramyocellular lipid droplets (HP:0012240) | 1.80642196 |
168 | Glycosuria (HP:0003076) | 1.80565711 |
169 | Abnormality of urine glucose concentration (HP:0011016) | 1.80565711 |
170 | Abnormality of iron homeostasis (HP:0011031) | 1.79873870 |
171 | Hypergonadotropic hypogonadism (HP:0000815) | 1.79742986 |
172 | Acute hepatic failure (HP:0006554) | 1.78928918 |
173 | Rough bone trabeculation (HP:0100670) | 1.78864036 |
174 | Broad face (HP:0000283) | 1.78354915 |
175 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78257954 |
176 | Viral hepatitis (HP:0006562) | 1.78233559 |
177 | Sensorimotor neuropathy (HP:0007141) | 1.77696814 |
178 | Villous atrophy (HP:0011473) | 1.77100355 |
179 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.77100355 |
180 | Epidermoid cyst (HP:0200040) | 1.76514163 |
181 | Abnormality of the tricuspid valve (HP:0001702) | 1.76198462 |
182 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.75831955 |
183 | Polygenic inheritance (HP:0010982) | 1.74021899 |
184 | Global brain atrophy (HP:0002283) | 1.73645935 |
185 | Thrombocytosis (HP:0001894) | 1.70867501 |
186 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.70532432 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.32115215 |
2 | PASK | 3.59129158 |
3 | CDK19 | 2.89808517 |
4 | SMG1 | 2.88365789 |
5 | ERN1 | 2.66898948 |
6 | WNK4 | 2.59047760 |
7 | MST1R | 2.56279152 |
8 | MAP3K2 | 2.54316135 |
9 | NME2 | 2.12924758 |
10 | PRPF4B | 2.10854396 |
11 | STK39 | 2.10640094 |
12 | KSR2 | 2.08173483 |
13 | VRK2 | 2.07948464 |
14 | ICK | 2.07544861 |
15 | TAOK3 | 2.04766919 |
16 | INSRR | 2.01824906 |
17 | STK16 | 1.94361663 |
18 | OXSR1 | 1.89713643 |
19 | FGFR4 | 1.83750040 |
20 | MAPK15 | 1.83205765 |
21 | MAP2K2 | 1.79476728 |
22 | SIK1 | 1.71629648 |
23 | IRAK3 | 1.70021184 |
24 | DAPK2 | 1.64879748 |
25 | PIK3CG | 1.60795367 |
26 | PIM2 | 1.58887741 |
27 | TRIB3 | 1.53561201 |
28 | PRKD3 | 1.50973357 |
29 | MAP3K13 | 1.49887724 |
30 | FLT3 | 1.44025028 |
31 | CAMKK1 | 1.41553884 |
32 | MARK3 | 1.33507608 |
33 | MAP4K1 | 1.29111287 |
34 | TNK2 | 1.26911599 |
35 | BLK | 1.23772121 |
36 | TBK1 | 1.23491462 |
37 | CDK12 | 1.22716987 |
38 | NTRK1 | 1.21419130 |
39 | MAPKAPK5 | 1.20903974 |
40 | KDR | 1.20447109 |
41 | TESK2 | 1.20239021 |
42 | LRRK2 | 1.19255825 |
43 | TYK2 | 1.16932167 |
44 | MAP3K1 | 1.13447867 |
45 | MET | 1.13353447 |
46 | TAOK2 | 1.11148130 |
47 | SCYL2 | 1.09114777 |
48 | IRAK4 | 1.09036407 |
49 | EPHA4 | 1.08696365 |
50 | EPHA2 | 1.06460086 |
51 | SIK3 | 1.03254762 |
52 | UHMK1 | 1.00128192 |
53 | MAP3K3 | 0.98006259 |
54 | TAOK1 | 0.97591163 |
55 | HIPK2 | 0.94905227 |
56 | NME1 | 0.94303630 |
57 | EPHB1 | 0.94116627 |
58 | NTRK3 | 0.94081774 |
59 | CSNK1G3 | 0.92924277 |
60 | KIT | 0.90384659 |
61 | ARAF | 0.89956270 |
62 | EEF2K | 0.87588994 |
63 | RIPK4 | 0.86174288 |
64 | CDK7 | 0.85836467 |
65 | BRAF | 0.85011139 |
66 | TESK1 | 0.82874043 |
67 | CAMKK2 | 0.81339065 |
68 | MAP3K8 | 0.80784434 |
69 | MAP2K1 | 0.80523008 |
70 | MAP3K11 | 0.78407558 |
71 | IRAK2 | 0.78247401 |
72 | EPHA3 | 0.76668747 |
73 | JAK2 | 0.75930475 |
74 | CSNK1G2 | 0.75857143 |
75 | EIF2AK3 | 0.75210340 |
76 | RAF1 | 0.74408242 |
77 | TLK1 | 0.74263430 |
78 | BMX | 0.73413452 |
79 | CDK4 | 0.71763000 |
80 | MAP2K4 | 0.71296400 |
81 | SYK | 0.71226513 |
82 | DAPK1 | 0.70823004 |
83 | GRK6 | 0.69785293 |
84 | MARK2 | 0.68697629 |
85 | PDK3 | 0.68269313 |
86 | PDK4 | 0.68269313 |
87 | RPS6KB2 | 0.68045021 |
88 | WNK3 | 0.67638719 |
89 | PTK6 | 0.66833160 |
90 | BTK | 0.66545320 |
91 | HCK | 0.65591811 |
92 | RET | 0.64877387 |
93 | PRKCI | 0.64393096 |
94 | CAMK2D | 0.64374876 |
95 | MTOR | 0.63531920 |
96 | CAMK2G | 0.62686285 |
97 | MAPKAPK3 | 0.62028278 |
98 | NEK2 | 0.61513816 |
99 | CAMK2B | 0.61466933 |
100 | IRAK1 | 0.60427082 |
101 | RPS6KC1 | 0.59843800 |
102 | RPS6KL1 | 0.59843800 |
103 | FES | 0.59786292 |
104 | IKBKE | 0.59754581 |
105 | PAK4 | 0.59627294 |
106 | PKN2 | 0.59592908 |
107 | CSF1R | 0.59412251 |
108 | MAPK12 | 0.59305349 |
109 | MAP3K6 | 0.59250464 |
110 | IKBKB | 0.58502133 |
111 | MAP2K6 | 0.58244947 |
112 | SIK2 | 0.58225268 |
113 | ZAP70 | 0.58183574 |
114 | ABL2 | 0.57662066 |
115 | CDK5 | 0.57594229 |
116 | PDPK1 | 0.56720079 |
117 | CSK | 0.56331576 |
118 | CLK1 | 0.56012514 |
119 | DAPK3 | 0.55644284 |
120 | PDK1 | 0.55539550 |
121 | MAP3K14 | 0.53891724 |
122 | JAK3 | 0.53859051 |
123 | LYN | 0.53832332 |
124 | AURKA | 0.53135707 |
125 | RPS6KA4 | 0.52727924 |
126 | CDK9 | 0.52585247 |
127 | RPS6KA2 | 0.52323299 |
128 | PIK3CA | 0.51700746 |
129 | PRKCH | 0.51538266 |
130 | GRK5 | 0.50956482 |
131 | MINK1 | 0.50507666 |
132 | TIE1 | 0.50468443 |
133 | TNIK | 0.49804123 |
134 | PRKD2 | 0.49436685 |
135 | ILK | 0.48859604 |
136 | MAP2K3 | 0.48630003 |
137 | CSNK1A1L | 0.48007906 |
138 | PAK1 | 0.47800085 |
139 | STK10 | 0.47598318 |
140 | MAP3K7 | 0.47169338 |
141 | PRKCG | 0.46736216 |
142 | MAP3K10 | 0.46592626 |
143 | ATR | 0.44762831 |
144 | TEC | 0.44216986 |
145 | PRKCZ | 0.43722728 |
146 | PAK3 | 0.43261518 |
147 | CSNK1G1 | 0.43037653 |
148 | RPS6KA5 | 0.41464724 |
149 | MAPK11 | 0.40815589 |
150 | TTN | 0.40626553 |
151 | MAPKAPK2 | 0.40236066 |
152 | CDK8 | 0.39885533 |
153 | RPS6KA6 | 0.38960349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.55871776 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.23068610 |
3 | Base excision repair_Homo sapiens_hsa03410 | 3.08829285 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77499238 |
5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.73949005 |
6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.61547333 |
7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46236709 |
8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.41758443 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.37450099 |
10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.32751905 |
11 | Protein export_Homo sapiens_hsa03060 | 2.32338003 |
12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.26270447 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.20799712 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19608507 |
15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.19109815 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.09620172 |
17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07638107 |
18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07380207 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.01612744 |
20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.00263691 |
21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96395397 |
22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93734694 |
23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.91531701 |
24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89593536 |
25 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70657693 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66811658 |
27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.65660856 |
28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.62074779 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.61738707 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.60106139 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59197912 |
32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57755975 |
33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.57343596 |
34 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.55210646 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53623727 |
36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53492636 |
37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51981043 |
38 | Mismatch repair_Homo sapiens_hsa03430 | 1.46912455 |
39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.46712698 |
40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45468438 |
41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43934943 |
42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37170182 |
43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29945603 |
44 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29796419 |
45 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28840498 |
46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28050023 |
47 | Apoptosis_Homo sapiens_hsa04210 | 1.25350495 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25223385 |
49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24963353 |
50 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24932485 |
51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23432842 |
52 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23063557 |
53 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19803135 |
54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19533867 |
55 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.19309979 |
56 | Bile secretion_Homo sapiens_hsa04976 | 1.17882240 |
57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17881016 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17830212 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17083222 |
60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16209626 |
61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15624675 |
62 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15240446 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.12294171 |
64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11742592 |
65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11004253 |
66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.09914918 |
67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09791094 |
68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07419489 |
69 | ABC transporters_Homo sapiens_hsa02010 | 1.03183476 |
70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02025559 |
71 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01023500 |
72 | Bladder cancer_Homo sapiens_hsa05219 | 1.01003869 |
73 | Spliceosome_Homo sapiens_hsa03040 | 1.00874275 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99823268 |
75 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97868024 |
76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97838979 |
77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97761495 |
78 | Homologous recombination_Homo sapiens_hsa03440 | 0.97741662 |
79 | Hepatitis C_Homo sapiens_hsa05160 | 0.96220294 |
80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96181248 |
81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94370034 |
82 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91952734 |
83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.91723376 |
84 | Tuberculosis_Homo sapiens_hsa05152 | 0.91664280 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90689648 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90031799 |
87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89666371 |
88 | Hepatitis B_Homo sapiens_hsa05161 | 0.89242321 |
89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.88874405 |
90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87962880 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87296294 |
92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86566587 |
93 | Influenza A_Homo sapiens_hsa05164 | 0.85550107 |
94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84924748 |
95 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.84811632 |
96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83608900 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83570181 |
98 | Shigellosis_Homo sapiens_hsa05131 | 0.82117393 |
99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81120870 |
100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78952837 |
101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77110275 |
102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77026159 |
103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75902429 |
104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75770020 |
105 | RNA polymerase_Homo sapiens_hsa03020 | 0.75580401 |
106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75457755 |
107 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74746198 |
108 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.74564147 |
109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72674330 |
110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.71965332 |
111 | Allograft rejection_Homo sapiens_hsa05330 | 0.69573523 |
112 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68906013 |
113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68393973 |
114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67918956 |
115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67882385 |
116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67800570 |
117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67782677 |
118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67584044 |
119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65487391 |
120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65312211 |
121 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64707428 |
122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63933883 |
123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63882742 |
124 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62689472 |
125 | Measles_Homo sapiens_hsa05162 | 0.61673268 |
126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61508879 |
127 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61270023 |
128 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61262069 |
129 | Legionellosis_Homo sapiens_hsa05134 | 0.59815095 |
130 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58922204 |
131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57690204 |
132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56603673 |
133 | Insulin secretion_Homo sapiens_hsa04911 | 0.55746517 |
134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54301718 |
135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54295920 |
136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53894090 |
137 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53170754 |
138 | Lysosome_Homo sapiens_hsa04142 | 0.52464954 |
139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51690609 |
140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51333473 |
141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51237988 |
142 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.51090809 |
143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50869996 |
144 | Platelet activation_Homo sapiens_hsa04611 | 0.49574253 |
145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49375274 |
146 | Purine metabolism_Homo sapiens_hsa00230 | 0.48256033 |
147 | Phagosome_Homo sapiens_hsa04145 | 0.47966142 |
148 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.47581715 |
149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47193943 |
150 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46527442 |
151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.46076145 |
152 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.45480560 |
153 | Insulin resistance_Homo sapiens_hsa04931 | 0.45473219 |
154 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44010195 |
155 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43542272 |
156 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43101199 |
157 | Endocytosis_Homo sapiens_hsa04144 | 0.42184726 |
158 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42051236 |
159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41852230 |
160 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41711935 |
161 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41203745 |
162 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41062863 |
163 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38771445 |
164 | Prion diseases_Homo sapiens_hsa05020 | 0.26814919 |
165 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.26216968 |
166 | Ribosome_Homo sapiens_hsa03010 | 0.24548519 |
167 | GABAergic synapse_Homo sapiens_hsa04727 | 0.23614411 |
168 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23450783 |
169 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.23013821 |
170 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19255504 |
171 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.15525033 |
172 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.14913225 |
173 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.12948455 |